Using a blood test to find active germ cell tumors
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This trial tests whether a blood test called miRNA-371 can detect active germ cell tumors in patients who have had surgery or are being watched. It may help guide treatment decisions without needing extra biopsies or scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery to remove a testicular tumor (orchiectomy) and it was a germ cell tumor.
- Your cancer is stage I, IIA, or IIB, or has spread only to lymph nodes in the back of the abdomen.
- If you have enlarged lymph nodes, they must be less than 3 cm and only 1 or 2 nodes are affected.
- You had imaging (CT or MRI) within the last 3 months (stage I) or 8 weeks (stage II).
- You are 18 or older.
- You have no other active cancer or uncontrolled medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to manage germ cell tumors in children and young adults using careful monitoring for some patients and chemotherapy for others. It aims to see whether these approaches can control the cancer while avoiding unnecessary treatment when possible.
This study is looking at a new marker called miRNA371 in people newly diagnosed with germ cell tumors. The goal is to see if it can help predict relapse and guide treatment decisions.
This study looks at whether a simple blood test (liquid biopsy) can help track germ cell tumors (testicular cancer). It may help doctors understand your disease better and guide your care.
This trial looks for signs of cancer DNA in your blood (circulating tumor DNA) to see if it can help track germ cell tumors. It may help doctors find out if your cancer is coming back earlier.
This study looks at tiny genetic signals called microRNAs to see if they can help identify or track testicular cancer. It may help doctors recognize testicular cancer more accurately and decide what to do next.
This trial tests a way for surgeons to find the first lymph nodes that testicular cancer might spread to, using a special camera and a dye. It could help doctors decide if you need extra treatment after surgery to remove the testicle.
Hear when a new Malignant Testicular Germ Cell Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.